Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease (IBD) have been dashed. The Massachusetts-based microbiome outfit’s mixture of 16 bacterial strains failed to ...

Mumbai: US short-seller Viceroy Research on Tuesday levelled new allegations at Vedanta Group, this time accusing Vedanta Ltd’s promoters of holding an undisclosed stake through a welfare trust, ...

The science of treating intestinal infections with a microbiome drug is progressing with at least four biotech companies developing such therapies, three of them in late-stage clinical trials.

Vedanta Biosciences has found investors willing to bankroll its phase 3 microbiome clinical trial. While a funding freeze recently forced Finch Therapeutics to fold its rival program, Vedanta has ...

Global brokerage house JP Morgan has reaffirmed its Overweight rating on Vedanta Resources Ltd (VRL), the parent company of Vedanta and its associated bonds, despite recent concerns raised by a ...

Taiwanese multinational electronics manufacturer Foxconn inked a JV agreement with India's Vedanta in September 2022. Taiwan’s Hon Hai Precision Industry, also known by its trade name Foxconn, has ...

This is the second dividend from the company in the current financial year (Image: Shutterstock) The dividend spotlight is back on Vedanta and this time, it is kicking off the financial year FY26 with ...